We are thrilled to announce that 53Biologics has been recognized by Pharma Source as one of Europe’s leading Contract Development and Manufacturing Organizations (CDMOs) for biologics production. This prestigious recognition highlights our relentless commitment to delivering high-quality biologics manufacturing services and innovative solutions to the pharmaceutical and biotech sectors.
A Milestone Achievement
Being named as one of the top European CDMOs is a significant milestone in our journey. Since our inception, 53Biologics has dedicated itself to being at the forefront of biologics production. With advanced capabilities in microbial expression systems, mammalian cell culture, and state-of-the-art GMP facilities, we have consistently pushed the boundaries of what’s possible in the field of biopharmaceutical manufacturing.
Our recognition by Pharma Source reaffirms our standing as a trusted partner for companies looking to advance their biologic drug development and production. This acknowledgment serves as a testament to our team’s expertise, hard work, and the high standards we hold ourselves to every day.
Why This Recognition Matters
Pharma Source is a well-respected authority in the pharmaceutical industry, providing trusted insights on key players within the contract development and manufacturing space. Their recognition places 53Biologics among the elite CDMOs across Europe, emphasizing our strengths in:
- End-to-End Biologics Manufacturing: From R&D and process development to clinical and commercial-scale manufacturing, our services span the entire drug development lifecycle.
- Flexibility in Production: With a wide range of production capacities, including microbial fermentation up to 2000L, and growing expertise in mammalian systems, we cater to various project scales and complexities.
- Commitment to Innovation: Our continuous investment in the latest single-use technologies and bioprocess optimization ensures efficient, scalable, and cost-effective biologics production.
A Trusted Partner in Biologics
At 53Biologics, we pride ourselves on being more than just a service provider. We partner closely with our clients, offering customized solutions tailored to their unique needs. Whether it’s a startup needing rapid development for clinical trials or an established company scaling up for commercial manufacturing, we provide agile, transparent, and high-quality services that make a difference.
Our one-stop-shop approach allows us to support our partners throughout the entire process, including regulatory compliance, supply chain management, and fill-and-finish services, all while maintaining the highest standards of safety and quality.
Moving Forward
As we continue to grow and expand our capabilities, this recognition from Pharma Source motivates us to aim even higher. We remain committed to helping our clients succeed by leveraging our deep technical expertise, state-of-the-art infrastructure, and dedication to innovation.
53Biologics will continue to push the envelope in biologics production, ensuring that we not only meet but exceed the expectations of our partners in the pharmaceutical and biotech industries.
Thank You
We want to extend our sincere gratitude to Pharma Source for this recognition and to our clients, partners, and dedicated team who have made this achievement possible. Together, we look forward to continuing our mission of “decoding biologics production” and bringing new, life-changing therapies to market.
About 53Biologics:
53Biologics is a Spanish CDMO specialized in decoding biologics production, from DNA to proteins. The company provide services from preclinical development to GMP manufacturing, supporting their clients in getting their biological products to market as quickly as possible.
For more information about the company and its services, please visit 53Biologics.com or contact the 53Biologics’ team through info@53biologics.com
